Literature DB >> 27200847

Pharmacoeconomic Analysis Tofacitinib Use in Rheumatoid Arthritis Treatment Scheme.

A Kulikov1, I Komarov1, I Zinchuk2.   

Abstract

Entities:  

Year:  2014        PMID： 27200847     DOI： 10.1016/j.jval.2014.08.2621

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain.

Authors:  F Navarro; J M Martinez-Sesmero; A Balsa; C Peral; M Montoro; M Valderrama; S Gómez; F de Andrés-Nogales; M A Casado; Itziar Oyagüez
Journal:  Clin Rheumatol       Date:  2020-04-17       Impact factor: 2.980

Review 2.  JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future.

Authors:  Jacopo Angelini; Rossella Talotta; Rossana Roncato; Giulia Fornasier; Giorgia Barbiero; Lisa Dal Cin; Serena Brancati; Francesco Scaglione
Journal:  Biomolecules       Date:  2020-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.